
About Abiezer Pharma Private Limited
Data last updated:
Abiezer Pharma Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC378553. Its GSTIN is 07AAUCA9439Q1ZI (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ram Deen and Shiv Bhagwan Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10/336 Khichripur, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.37 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net loss of ₹1.81 Lakh (net margin -132.1%) and EBITDA of -₹1.81 Lakh (EBITDA margin -132.1%). Revenue has grown at a compounded annual rate (CAGR) of 132% over three years.
Abiezer Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0010116). For more details, the company can be reached via its website abiezerpharma.com.
Company details
Recognitions & Rankings of Abiezer Pharma
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-02-0010116
Contact details
Abiezer Pharma Private Limited's registered office is in Delhi, Delhi. Its website is abiezerpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address10/336 Khichripur, Delhi, India – 110091
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Abiezer Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Abiezer Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Abiezer Pharma Private Limited, buy the company report.
Financials of Abiezer Pharma Private Limited
FY 2025 filings availableAbiezer Pharma Private Limited reported revenue of ₹1.37 Lakh (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 132% over three years, including 38% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -132.1% | ||||
| Net Profit Margin | -132.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abiezer Pharma Private Limited, buy the company report.
Board of directors of Abiezer Pharma Private Limited
Abiezer Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Deen | Director | 15 Mar 2021 | 5 Years 7 Months | Current |
| Shiv Bhagwan Tiwari | Director | 15 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Abiezer Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Azymus Lifesciences Private Limited | ₹1.38 Lakh (FY 2024) | -66.0% | Chamarajanagar, Karnataka, India | |||
| Abiezer Pharma Private Limitedthis company | ₹1.37 Lakh (FY 2025) | -₹1.81 Lakh | -132.1% | 38.0% | Delhi, India | |
| Adore Meditech Private Limited | ₹1.37 Lakh (FY 2025) | 10.0% | Chandigarh, India | |||
| Buddy's Medicare Private Limited | ₹1.36 Lakh (FY 2025) | 46.0% | Bhubaneswar, Odisha, India | |||
| Azalea Life Sciences Private Limited | ₹1.34 Lakh (FY 2025) | 43.0% | S.G.Highway, Sarkhej, Gujarat, India |
To see the full peer comparison of Abiezer Pharma Private Limited, buy the company report.
Auditor
Abiezer Pharma Private Limited is audited by M M H & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M M H & CO. | FY 2023 | 024407N |
Shareholding
The shareholding of Abiezer Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Abiezer Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Abiezer Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abiezer Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Abiezer Pharma Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
Abiezer Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAUCA9439Q1ZI | Delhi | Active | 07 Jul 2021 |
To see the full GST registrations and return filing status of Abiezer Pharma Private Limited, buy the company report.
Recent activity
Abiezer Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ram Deen was appointed as Director on 15 Mar 2021.
Frequently asked questions
Abiezer Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 March 2021 (5+ years old) and is registered under CIN U51909DL2021PTC378553.
Abiezer Pharma has 2 current directors:
- Ram Deen - Director
- Shiv Bhagwan Tiwari - Director
The latest financial statements of Abiezer Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Abiezer Pharma is 07AAUCA9439Q1ZI, registered in Delhi.
The CIN (Corporate Identification Number) of Abiezer Pharma is U51909DL2021PTC378553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abiezer Pharma was incorporated on 15 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Abiezer Pharma by revenue are Azymus Lifesciences Private Limited, Adore Meditech Private Limited, Buddy's Medicare Private Limited, Azalea Life Sciences Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ram Deen was appointed as Director on 15 Mar 2021. Shiv Bhagwan Tiwari was appointed as Director on 15 Mar 2021.
Yes, Abiezer Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Abiezer Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0010116).
Abiezer Pharma can be reached through the website abiezerpharma.com. Its registered office is in Delhi, India.